Clinical Trial Update: Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the effect of febuxostat on joint damage in hyperuricemic subjects with early gout; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Takeda | Conditions: Joint Damage | Phase 2 | Status: COMPLETED | Results posted: 2014-09-10